Reply to D.-C. Mo et al
- PMID: 36669137
- DOI: 10.1200/JCO.22.02741
Reply to D.-C. Mo et al
Comment on
-
Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer.J Clin Oncol. 2023 Mar 20;41(9):1790. doi: 10.1200/JCO.22.02398. Epub 2023 Jan 20. J Clin Oncol. 2023. PMID: 36669141 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
